ArticlePDF Available

A Practical Guideline for Calculating Parenteral Nutrition Cycles

Authors:

Abstract and Figures

Both physiologic and psychological reasons for cycling total parenteral nutrition (TPN) have been well established. Despite widespread acceptance of this practice, the only previously published method for calculating TPN cycle rates is inherently flawed. A mathematical formula was derived to facilitate reliable calculation of cyclic TPN flow rates as a function of total volume and cycle time. A publicly accessible website was subsequently developed to expedite rapid determination of TPN cycles. A fail-safe method of calculating TPN cycle flow rates can be expressed as F = V/(4T-10), where F is equal to the basal flow rate (mL/h), T is equal to the desired cycle time (hours), and V is equal to the total volume of TPN (mL) to be delivered in 24 hours. The basal flow rate and twice the basal flow rate are used for the first and last 2 hours of the TPN cycle, and the remainder of the cycle runs at 4 times the basal flow rate. TPN cycles may be easily calculated online using this formula at http://peds.stanford.edu/tpn.html. We have developed a fail-safe method of calculating TPN cycle flow rates that will consistently deliver the desired volume and have made an online implementation of this formula publicly available.
Content may be subject to copyright.
Techniques and Procedures
A Practical Guideline for Calculating Parenteral Nutrition Cycles
Chris Longhurst, MD, MS*; Louie Naumovski, MD, PhD†; Manuel Garcia-Careaga, MD‡; and
John Kerner, MD‡
*Department of Pediatrics, †Division of Hematology-Oncology, Department of Pediatrics, and ‡Division of
Gastroenterology and Nutrition, Department of Pediatrics, Stanford University, Stanford, California
ABSTRACT: Background: Both physiologic and psycho-
logical reasons for cycling total parenteral nutrition (TPN)
have been well established. Despite widespread accep-
tance of this practice, the only previously published
method for calculating TPN cycle rates is inherently
flawed. Methods: A mathematical formula was derived to
facilitate reliable calculation of cyclic TPN flow rates as a
function of total volume and cycle time. A publicly acces-
sible website was subsequently developed to expedite
rapid determination of TPN cycles. Results: A fail-safe
method of calculating TPN cycle flow rates can be
expressed as F V/(4T-10), where F is equal to the basal
flow rate (mL/h), T is equal to the desired cycle time
(hours), and V is equal to the total volume of TPN (mL) to
be delivered in 24 hours. The basal flow rate and twice the
basal flow rate are used for the first and last 2 hours of the
TPN cycle, and the remainder of the cycle runs at 4 times
the basal flow rate. TPN cycles may be easily calculated
online using this formula at http://peds.stanford.edu/
tpn.html. Conclusions: We have developed a fail-safe
method of calculating TPN cycle flow rates that will
consistently deliver the desired volume and have made an
online implementation of this formula publicly available.
Cycling total parenteral nutrition (TPN) refers to
the technique of infusing a daily solution in a 24-
hour period of time. Theoretical advantages of cyclic
TPN include prevention or treatment of TPN-induced
fatty infiltration of the liver, prevention or treatment
of essential fatty acid deficiency, more rapid restora-
tion of albumin levels, prevention of the hyperinsulin-
ism of continuous TPN, and prevention of lipogenesis
(which can increase the respiratory quotient).
1
In
1994, Collier and colleagues
2
published a study in
which they observed stabilization or improvement in
direct bilirubin concentrations of 8 of 10 infants 6
months of age after initiating cyclic TPN. Several
years later, Meehan and Georgeson
3
published the
promising results of a retrospective analysis using
cyclic TPN as part of a comprehensive protocol to
prevent liver failure in parenteral nutrition–depen-
dent children with short bowel syndrome. Even more
recently, Hwang and colleagues
4
published a prospec-
tive, controlled trial in which they concluded that early
TPN cycling prevented further deterioration of liver
function in jaundiced patients who required prolonged
parenteral nutrition support.
Although the initial impetus behind cyclic TPN as
first described by Maini and coworkers
5
was to
confer a physiologic advantage over continuous infu-
sion, it is now well accepted that the psychological
benefits are equally tangible for many patients.
Freedom from the infusion apparatus allows for
greater social activity and interaction, and children,
in particular, may benefit from increased school
attendance and the opportunity to participate in
sports programs. Indeed, one of the earliest prospec-
tive studies of nocturnal TPN in hospitalized adults
suggested that “a main satisfaction of the present
technique was the appreciable comfort of the hospi-
talized patients” with subsequent improvement in
morale and acceptance of treatment.
6
The most important practical aspect of cycling
TPN is calculating tapered flow rates so that glucose
infusions are started and stopped slowly to prevent
potentially harmful fluctuations in blood glucose. It
is well known that hyperglycemia can be induced by
the rapid initiation of TPN
7
and clinical experience
with pediatric patients has shown that rebound
hypoglycemia can occur with acute discontinuation,
although the evidence in adult patients differs.
8,9
Given the substantial body of research supporting
the use of cyclic TPN in appropriately selected
patients, it is somewhat surprising that so few
guidelines for calculating these TPN cycles exist.
The Old Method
To our knowledge, Faubion et al have published
the only guideline for calculating TPN cycle flow
rates,
10
and their method is referenced in several
Correspondence: John Kerner, MD, Pediatric Gastroenterology,
Lucile Salter Packard Children’s Hospital, 750 Welch Road #116,
Palo Alto, CA 94304. Electronic mail may be sent to
john.kerner@stanford.edu.
0884-5336/03/1806-0517$03.00/0
Nutrition in Clinical Practice 18:517–520, December 2003
Copyright © 2003 American Society for Parenteral and Enteral Nutrition
517
textbooks.
1,11,12
Unfortunately, this formula is
inherently awed and can cause patients to inadver-
tently receive an incorrect volume of nutrition sup-
port and therefore an incorrect amount of caloric
support. The problem with the method they
described is that ow rates are not calculated to
deliver 100% of the desired TPN volume. Rather, the
authors recommended calculating a peak infusion
rate by dividing 90% of the total volume by the
desired cycle time minus 4 hours, and the ramping
rates are simply one-half and one-quarter of this
peak ow rate. Therefore, whereas 90% of the TPN
will always be delivered during the time of peak
ow, either too much or too little volume may be
administered during the remainder of the infusion.
When the Faubion method is mathematically
deconstructed (data not shown), it becomes clear
that the percent of introduced error varies inversely
with the cycle time and independently of the desired
cycle volume (Fig. 1). In fact, ow rates calculated
using this method will deliver the correct volume
only at a cycle time of exactly 17
1
2
hours. If the
calculated ow rates are precisely administered,
TPN cycles longer than 17
1
2
hours will always
deliver too little TPN (2.5% less in a 22-hour cycle),
and shorter cycles will always result in a greater
volume administered than desired (6.9% more at 12
hours and 23.8% more at 8 hours). For example, a
5-kg infant receiving 120 mL/kg/day of TPN cycled
over 12 hours would receive 641 mL of TPN per day
rather than the desired 600 mL. It is conceivable
that such an error could become clinically signicant
over several days, depending on the patients under-
lying condition and the length of therapy.
A New Method
We have developed a more reliable method of
calculating cyclic TPN ow rates for the patients of
Lucile Packard Childrens Hospital at Stanford Uni-
versity. An abstract TPN cycle was conceived such
that the total desired volume is delivered at a basal
rate during the rst and last hour of the cycle, twice
that rate during the second and penultimate hour,
and 4 times the basal rate during the remainder of
the cycle. Because the product of the basal ow rate
(F) and the time spent owing at that rate yields the
volume delivered in that time, given any total cycle
time (T), we can express the total TPN volume (V)of
that cycle as:
V 1F 2F 4F(T 4) 2F 1F
Solving for the basal ow rate, our equation
becomes:
6F 4F(T 4) V
6F 4FT 16F V
4FT 10F V
F(4T 10) V
F V/(4T 10)
Thus the basal ow rate of any TPN cycle can be
calculated by dividing the total volume to be deliv-
ered by the sum of 4 times the total cycle time minus
10 (Fig. 2).
Suppose a patient requires TPN with a total
volume of 1400 mL per day. Although this amount
would typically be delivered at 58.3 mL/h continu-
ously, if the same volume is to be cycled over 20
hours, our equation yields a basal ow rate of 20
mL/h. Therefore, the TPN should ow at 20 mL/h
during the rst and last hour, 40 mL/h during the
second and penultimate hour, and 80 mL/h during
the remaining 16 hours. Similarly, the same volume
administered over a 12-hour cycle will ow at rates
Figure 1. The previously published guideline for cycling TPN can deliver signicantly different volumes of TPN than
desired.
518 Vol. 18, No. 6LONGHURST ET AL
of 36.8 mL/h, 73.7 mL/h, and 147.4 mL/h during the
times indicated above.
The Online Implementation
This formula has been widely used to calculate
TPN cycles at our institution for 10 years.
Although a spreadsheet was previously used to
facilitate calculations, a web-based version was
more recently developed for easier accessibility (Fig.
3). We welcome the reader to use this free tool
located online at http://peds.stanford.edu/tpn.html.
By entering the TPN volume and the number of
Figure 2. A mathematical overview of the method used to cycle TPN at Lucile Packard Childrens Hospital using a
22-hour cycle for illustration purposes.
Figure 3. The TPN cycle calculator available online at http://peds.stanford.edu/tpn.html.
December 2003 519CALCULATING PARENTERAL NUTRITION CYCLES
hours over which it should be cycled, users can
instantly calculate ow rates that, when adminis-
tered correctly, will always deliver the desired vol-
ume. A link with an example of a typical order for
cycling TPN can also be found on the same website.
Of note, the importance of using a similar online tool
to prevent medical errors was recently established
in a paper that also convincingly demonstrated that
such a tool rapidly gained enthusiastic support from
users.
13
Discussion and Future Directions
In conclusion, we have developed a rapid and
reliable method for calculating TPN cycle ow rates,
given the total volume of TPN and total cycle time. It
is important to note, however, that the division of
increasing and decreasing the rate by 1-hour time
blocks is arbitrary. Using the same mathematical
concepts, the TPN cycle ow rates could easily be
increased and decreased over any amount of time.
We did not investigate the physiologic effects of such
cycling. Additionally, our tool does not calculate
glucose infusion rates, a particular concern in the
neonatal intensive care unit. Further studies are
necessary to determine the optimal time over which
TPN rates can be increased and decreased and to
better elucidate the physiologic benets and draw-
backs of such cycles. We encourage future research-
ers to use a mathematically accurate method for
calculating cycle ow rates in order to maintain
consistent and accurate delivery of desired TPN
volumes.
Acknowledgments
We thank Dr Stuart Turner, DVM, MS, for devel-
oping a Palm handheld-based version of the TPN
cycling program, also available at http://peds.stan-
ford.edu/tpn.html. We thank Dr Monte Klaudt for
reviewing this manuscript. The work was supported
in part by the Carl and Patricia Dierkes Endowed
Fund for Nutrition and Home Care.
References
1. Kerner JA. Cyclic TPN for hospitalized pediatric patients. In:
Kerner JA, ed. Manual of Pediatric Parenteral Nutrition. New
York, NY: Wiley Medical; 1983:307311.
2. Collier S, Crouch J, Hendricks K, Caballero B. Use of cyclic
parenteral nutrition in infants less than 6 months of age. Nutr
Clin Pract. 1994;9:6568.
3. Meehan JJ, Georgeson KE. Prevention of liver failure in paren-
teral nutrition-dependent children with short bowel syndrome.
J Pediatr Surg. 1997;32:473475.
4. Hwang TL, Lue MC, Chen LL. Early use of cyclic TPN prevents
further deterioration of liver functions for the TPN patients with
impaired liver function. Hepatogastroenterology. 2000;47:1347
1350.
5. Maini B, Blackburn GL, Bistrian BR, et al. Cyclic hyperalimen-
tation: an optimal technique for preservation of visceral protein.
J Surg Res. 1976;20:515.
6. Matuchansky C, Morichau-Beauchant M, Druart F, et al. Cyclic
(nocturnal) total parenteral nutrition in hospitalized adult
patients with severe digestive diseases. Gasteroenterology. 1981;
81:433437.
7. Wood RJ, Bengoa JM, Rosenberg IH. Urinary C-peptide measure-
ments in patients receiving continous and cyclic TPN. J Lab Clin
Med. 1985;105:259264.
8. Wagman LD, Newsome HH, Miller KB, et al. The effect of acute
discontinuation of TPN. Ann Surg. 1986;204:524529.
9. Nirula R, Yamada K, Waxman K. The effect of abrupt cessation of
TPN on serum glucose: a randomized trial. Am Surg. 2000;66:
866869.
10. Faubion WC, Baker WB, Iott BA, et al. Cyclic TPN for hospital-
ized pediatric patients. Nutr Support Serv. 1981;1:2425.
11. Davis AM. Initiation, monitoring, and complications of pediatric
parenteral nutrition. In: Baker RD, Baker SS, Davis AM, eds.
Pediatric Parenteral Nutrition. New York, NY: Chapman & Hall;
1997:220222.
12. Collier SB, Richardson DS, Gura KM, et al. Parenteral nutrition.
In: Hendricks KM, Duggan C, Walker WA, eds. Manual of
Pediatric Nutrition. 3rd ed. Ontario, Canada: B. C. Decker;
2000:259263.
13. Lehmann CU, Conner KG, Cox JM. Provider error prevention:
online total parenteral nutrition calculator. Proceedings of the
AMIA annual symposium. 2002;435439.
520 Vol. 18, No. 6LONGHURST ET AL
... -Se deben desarrollar protocolos y procedimientos estandari- zados escritos para la administración de la NP (3,8). -Se debe comprobar el etiquetado de la bolsa de la NP: que corresponda al paciente, la composición prescrita, la vía de administración (central o periférica), la velocidad de infusión y la caducidad (3,8). ...
... -Se deben desarrollar protocolos y procedimientos estandari- zados escritos para la administración de la NP (3,8). -Se debe comprobar el etiquetado de la bolsa de la NP: que corresponda al paciente, la composición prescrita, la vía de administración (central o periférica), la velocidad de infusión y la caducidad (3,8). -La bolsa de NP se debe almacenar en la nevera a una tem- peratura entre 2° y 8 °C. ...
Article
Full-text available
El oxígeno y/o la luz son los principales causantes de la degradación de los componentes de la nutrición parenteral (NP), especialmente de vitaminas y lípidos. La oxidación de algunas vitaminas y la peroxidación lipídica son catalizadas por la luz, siendo la presencia de oxígeno el factor decisivo del proceso. El material de la bolsa en contacto con la NP debe ser químicamente inerte, como el etilvinilacetato (EVA) o el polipropileno. El cloruro de polivinilo (PVC), además de ceder a los lípidos el plastifi cante tóxico dietilhexilftalato (DEHP), también adsorbe otros componentes de la NP.
... According to the Stanford TPN model (Longhurst et al. 2003), the TPN dosing cycle is formulated based on the infusion volume (V), base flow rate (F b ) and the transition time (t) as represented in Eq. ...
Article
Full-text available
In a drug delivery system, a piezoelectric micropump plays a vital role to deliver precise volume and concentration of the drug. Micropump in the modern infusion system should vary the flow rate of the drug according to prescribed infusion volume and profile. However, piezo actuated micropumps create intermittent flow due to flow pulsations. In this paper, a novel digital offset switching (DOS) strategy was proposed to develop desired uniform flow, minimize flow pulsations and reduce medication error. The proposed strategy was implemented on the developed digital multiple micropump infusion system (DMMIS). The unique configuration of DMMIS contains a parallel arrangement of piezoelectric micropumps with associated drivers, controller, sensors, and instrumentation. The flow capacity of multiple piezoelectric micropumps was sized with binary and Fibonacci sequence based sizing techniques. Comprehensive experimental studies were conducted to analyse the effectiveness of the proposed switching strategy when compared to existing parallel switching and sequential switching strategies. Wherein, three dosing cycles were formulated to study the effect of switching strategies on flow characteristics. The optimal dosing cycle was selected based on the mean absolute percentage error (MAPE), degree of flow pulsation (DFP), and absolute medication error percentage (AMEP). The results show that the binary dosing cycle with the DOS strategy was the optimal dosing cycle with 7.51% MAPE, 5.14% DFP, and 4.6% AMEP. The experimental studies have reported that the DOS strategy has effectively minimized the MAPE, DFP, and AMEP in dosing cycles.
Article
In pediatric patients with intestinal failure, parenteral nutrition is lifesaving but also has several associated risks. The goals of intestinal rehabilitation include promoting growth, minimizing complications associated with intestinal failure, and reaching enteral autonomy, if possible. Pediatric intestinal rehabilitation programs are interdisciplinary teams that strive to provide optimal care for children dependent on parenteral nutrition. The provision of parenteral nutrition requires close monitoring of patients' growth, nutrition concerns, clinical status, and laboratory parameters. Recent advances in the field of intestinal rehabilitation include new lipid emulsions, considerations regarding enteral feeding, advances in micronutrient provision, and central venous catheter preservation techniques. Challenges in the field remain, including improving overall quality of life with home parenteral nutrition administration and preventing recently recognized complications such as chronic intestinal inflammation.
Article
Handheld computers, or personal digital assistants (PDAs), have been used to assist clinicians in medical nutrition since the early 1980s. The term PDA was originally applied to programmable calculators; over time, the capabilities of these devices were expanded to allow for the use of more complicated programs such as databases, spreadsheets, and electronic books. Slowly, the device evolved into what is more commonly thought of as a PDA, that is, a device such as a PalmOS (PalmSource, Inc, Tokyo, Japan) or PocketPC (Microsoft, Redmond, WA) unit. We present a review of the literature about the use of PDAs in medical nutrition, followed by a discussion of the different types of PDAs and mobile technologies that are commercially available. This is followed by a discussion of software applications that are currently available for use by nutrition clinicians, focusing on freeware applications. Finally, future technologies and applications are discussed.
Article
The present study was undertaken in 14 patients to evaluate the usefulness of ''cyclic hyperalimentation'' in alleviating the unfavorable effects of continuous infusion of hypertonic glucose on the liver. Cyclic hyperalimentation is a name provided for a parenteral feeding technique providing amino acid infusions during the entire day but where administration of hypertonic dextrose is discontinued during part of the day. This allows for the development of a postabsorptive state, facilitating the mobilization and utilization of calories stored as fat during the hypertonic dextrose infusion. Furthermore, it is hoped that the amino acids supplied during periods of reduced insulin secretion would be less avidly taken up by muscle compartment and that this would favor protein synthesis in the visceral compartment. The data reported here indicates that cyclic hyperalimentation is better tolerated by the liver than ''continuous hyperalimentation'' and that in fact it allows recovery of hepatic damage incurred during continuous therapy with hypertonic glucose. Restoration of albumin levels occurs more rapidly during cyclic hyperalimentation than during conventional parenteral hyperalimentation. Cyclic hyperalimentation can be further improved where possible by substituting limited oral intake of protein for the intravenous infusion of isotonic amino acids during the dextrose free period.
Article
The present study was undertaken to assess the impact of acute discontinuation (AD) of total parenteral nutrition (TPN) on serum glucose, insulin, and glucagon levels and on the generation of symptomatic hypoglycemia. Fifty studies were performed in 48 patients. In none of the 30 studies of 1 hour duration nor in the 20 studies of 8 hours duration was there a single episode of symptomatic hypoglycemia. One patient had a glucose below normal (60 mg/dl) during the first hour after AD. Glucose and insulin concentrations were elevated at the start of TPN discontinuation but returned to normal values within 60 minutes and remained there during the successive 7 hours of study. Although glucagon levels were slightly elevated at zero time, no significant decrease occurred. There was no evidence for counter-regulation based on the patterns of glucose and hormone levels. With some restrictions, acute discontinuation is a safe, rapid method of ending a prolonged TPN infusion.
Article
Urinary C-peptide excretion has been found to be an accurate index of insulin secretion under a variety of physiologic conditions, such as acute starvation and exercise, and after oral and intravenous glucose administration. We investigated urinary C-peptide responses in a group of patients who were receiving all of their nutrient intake by intravenous administration. In these patients receiving total parenteral nutrition (TPN), we were able to monitor changes in insulin secretion when the same nutrients were infused at different rates, for example, during cyclic vs. continuous TPN administration, and to observe changes in the insulin secretory response as the pattern of nutrient delivery was altered in the same individual. We found that increasing the TPN infusion rate by 50% during cyclic TPN caused a 65% increase in serum insulin levels over levels observed during continuous TPN administration (93 vs. 60 microU/ml), whereas a 100% increase in the cyclic TPN infusion rate above the continuous TPN rate increased insulin levels by 147% (147 vs. 60 microU/ml). The molar ratio of insulin to C-peptide was increased by increasing rates of TPN infusion, from 0.116 during fasting periods to 0.151 during maximum rates of TPN administration. An additional finding of this study is that 24-hour insulin secretion, estimated by urinary C-peptide measurements, was equivalent in all treatments regardless of the pattern of insulin response elicited.
Article
Although continuous (24-h) total parenteral nutrition in hospital and discontinuous (cyclic) total parenteral nutrition at home are well-established, efficient methods of nutritional support, very little information is available on the early use of cyclic total parenteral nutrition in hospitalized, malnourished acute patients. In a prospective study, we used nocturnal cyclic total parenteral nutrition over 12-h infusion periods as a primary method of nutritional support in 27 consecutive acute patients hospitalized for severe malnutrition due to various gastrointestinal disorders. Mean duration of this method was 65 days (range, 21-170 days). The nonprotein energy source was provided by fat (40%) and hypertonic glucose (60%). After only 3 days of continuous intravenous feeding, the catheter was obturated and disconnected daily from 8 AM to 8 PM. The patients were totally starved during the day and were able to have various physical activities including washing, dressing up, and walking in and out of the wards. Cyclic total parenteral nutrition was associated with a significant improvement in nutritional status as assessed by weight gain, anthropometric measurements (p < 0.005), serum albumin (p < 0.01), nitrogen balance, and creatinine/height index (p < 0.001). Tolerance to treatment and acceptance of hospitalization were good in all patients but one. A low incidence of catheter infection (one case of septicemia due to a Staphylococcus epidermitis) and of metabolic complications (4 cases of consistent, reversible hypertriglyceridemia) was observed. It is suggested that nocturnal cyclic total parenteral nutrition is a safe, efficient, and psychologically well-tolerated method of nutritional support in hospitalized malnourished patients with severe gastrointestinal disorders. From an economic point of view, the daily cost of this method was 53% lower than that of patients treated in the intensive care unit for gastrointestinal diseases.
Article
Cyclic parenteral nutrition is the technique of infusing the intravenous solution in less than 24 hours, during a portion of the day or night, allowing the patient freedom from the intravenous tubing and pump apparatus. In addition, adverse effects of long-term parenteral therapy, such as liver complications, were reported to be decreased with the use of cyclic parenteral nutrition in adult patients. Literature on the method and effects of cycling in young infants is minimal. This report describes cyclic parenteral nutrition use with guidelines for cycling and the potential beneficial metabolic effects in 10 infants less than 6 months of age who required long-term parenteral nutrition support. Diagnosis, gestational age, length of time on parenteral nutrition, macronutrient intake, growth, and biochemical parameters for the patients are presented. Overall, cyclic parenteral nutrition was well tolerated without clinical symptoms of hypoglycemia, elevated capillary blood glucose concentrations, or abnormal urine glucose levels. The direct bilirubin concentrations showed a decrease or stabilization after cycling was initiated in eight of 10 patients.
Article
Progressive liver failure in parenteral nutrition (PN)-dependent children with short bowel syndrome carries significant morbidity and mortality. The authors retrospectively reviewed 47 consecutive patients with short bowel syndrome diagnosed from October 1985 through October 1995. All patients were treated according to a protocol designed to promote intestinal motility and discourage bacterial translocation. Elements of the protocol included the use of taurine, vigilant prevention and aggressive treatment of sepsis, meticulous catheter care, early PN cycling, appropriate enteral feeding, and measures designed to inhibit gastrointestinal bacterial translocation, especially gram-negative rods. Complete blood counts and serum liver function studies were compiled from both clinic visits and hospital admissions for each patient every 3 to 6 months while they were on PN. Three patients were lost to follow-up after they had moved out of state. The length of time on PN ranged from 3 months to 9.4 years with an average of 2.2 years. Elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT), and glutamyltransferase (GGT) were present in 82%, 66%, and 84% of patients, respectively. Alkaline phosphatase was elevated in 58% of patients. Eight patients (18%) are still on PN, and 31 (70%) have been weaned off PN. Five patients have died (11%). Three patients (7%) developed cholecystitis requiring cholecystectomy. No patients developed progressive liver failure. These results suggest that PN-related liver failure may be prevented in most patients with short bowel syndrome. Specific measures to prevent PN-related cholestatic jaundice need further investigation.
Article
The common clinical practice of gradually tapering total parenteral nutrition (TPN) to prevent hypoglycemia may be unnecessary. This randomized prospective study assessed the blood glucose profiles of patients whose TPN was abruptly discontinued in comparison with those whose TPN was gradually tapered to determine whether abrupt cessation can be performed safely. Patients were randomized into the abrupt cessation or the tapered protocol. A symptomatic hypoglycemic questionnaire was administered at regular intervals. Fingerstick glucose sampling was performed at 30-minute intervals and compared prospectively. From October 1996 through July 1997, 21 patients receiving TPN consented to participate in this study. Inclusion criteria included 1) duration of TPN infusion >24 hours, 2) age >18 years, and 3) establishment of enteral feeding at the time of TPN discontinuation. Patients had a baseline blood glucose level followed by repeat glucose measurements at 30-minute intervals until 90 minutes after TPN was completely discontinued in the tapered group and 120 minutes after cessation in the abrupt group. The rate of TPN tapering was in 25 per cent increments over 90-minute intervals. Ten patients were randomized into the tapered group and 11 patients in the abrupt group. None of the patients developed symptomatic hypoglycemia. There was no difference between the lowest blood glucose in the abrupt group in comparison with that of the tapered group (108.6+/-11.5 vs 108.2+/-9.8 respectively; P = 0.98). No patient had a significant change in hypoglycemia questionnaire score. There was no significant difference in age, duration of TPN, steroid use, or enteral caloric intake between the two groups. We conclude that there was no symptomatic hypoglycemia, and glucose profiles returned to a similar baseline level in those whose TPN was abruptly stopped when compared with those in the tapered group. These data demonstrate that patients receiving TPN can have parenteral nutrition abruptly stopped without the development of significant hypoglycemia.
Article
Impaired liver function is frequently found in patients who need prolonged total parenteral nutrition. Cyclic total parenteral nutrition can minimize the adverse effects of long-term total parenteral nutrition, such as hepatic complication. The adequate timing to shift to use cyclic total parenteral nutrition for patients with impaired liver function may prevent further hepatic dysfunction. A prospective study of 65 patients who need total parenteral nutrition and have impaired liver functions was performed. Cyclic total parenteral nutrition was used in different groups of patients, when their total bilirubin levels were just over 5 mg%, 10 mg%, or 20 mg% during the course of total parenteral nutrition. The patients of control groups received straight non-cyclic total parenteral nutrition. All the patients had stable vital signs without major stress, such as sepsis or acute bleeding. Ten patients (A2) in Group A were shifted to cyclic total parenteral nutrition when their total bilirubin was just over 5 mg%; the other 10 patients (A1) continued the non-cyclic total parenteral nutrition. Eleven patients (B2) in Group B were shifted to cyclic total parenteral nutrition when their total bilirubin was just over 10 mg%; the other 11 patients (B1) continued the non-cyclic total parenteral nutrition. Ten patients (C2) in Group C were shifted to cyclic total parenteral nutrition when their total bilirubin was just over 20 mg%; the other 13 patients (C1) continued the non-cyclic total parenteral nutrition. The average energy intake among 3 groups had no difference. Their liver functions were examined each week for 2 weeks. The results showed that the patients with non-cyclic total parenteral nutrition had significant increase of direct-total bilirubin and alkaline phosphatase (P < 0.05) in Group A and significant decrease of albumin accompanied with increase of GOT, GPT, direct/total bilirubin (P < 0.05) in Group B. The patients either using cyclic or non-cyclic total parenteral nutrition showed significant decrease of albumin and increase of direct/total bilirubin (P < 0.05) in Group C. We conclude that the early use of cyclic total parenteral nutrition may prevent deterioration of liver function for the patients with jaundice and need prolonged total parenteral nutrition.